Search company, investor...

Elypta

Analyst Briefing Submitted

elypta.com

Executives

Board of Directors

Elypta Management Team

4 Team Members

Elypta has 4 executives. Elypta's founder is Francesco Gatto. Elypta's is .

Name	Work History	Title	Status
Francesco Gatto	University of California San Diego, and Chalmers University of Technology	Founder	Current
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Name	Francesco Gatto	Subscribe to see more	Subscribe to see more	Subscribe to see more
Work History	University of California San Diego, and Chalmers University of Technology	Subscribe to see more	Subscribe to see more	Subscribe to see more
Title	Founder	Subscribe to see more	Subscribe to see more	Subscribe to see more
Status	Current	Subscribe to see more	Subscribe to see more	Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

Elypta Board of Directors

2 Board of directors

Elypta has 2 board of directors, including Anders Ekblom.

Name	Firm	Work History	Other Seats
Anders Ekblom		Dr. Ekblom has substantial experience from senior positions in the biopharmaceutical industry. He has been the executive vice president of Global Medicines Development at AstraZeneca, and the CEO of AstraZeneca Sweden AB. Currently, he is a board member of a number of life science companies.	Elypta
Jonas Jendi		Jonas has been focused on the commercialization of life science innovation for about 20 years. Between 2001 and 2010, Jonas was the CEO of Cogmed, a start-up in the field of evidence-based cognitive training (clinically validated software), based in Stockholm and later in the US. Jonas took the company from the research phase at the Karolinska Institute in 2001, to acquisition by Pearson, in 2010. Before joining Industrifonden in 2017, Jonas also held various advisor and board member roles, in both early stage and public companies, and across digital health (such as Shim, acquired by Kry), medtech and biotech (such as Bioinvent). His background also includes strategy work with The Boston Consulting Group. Jonas holds a M.Sc. from the Stockholm School of Economics.	Elypta

Name	Anders Ekblom	Jonas Jendi
Firm
Work History	Dr. Ekblom has substantial experience from senior positions in the biopharmaceutical industry. He has been the executive vice president of Global Medicines Development at AstraZeneca, and the CEO of AstraZeneca Sweden AB. Currently, he is a board member of a number of life science companies.	Jonas has been focused on the commercialization of life science innovation for about 20 years. Between 2001 and 2010, Jonas was the CEO of Cogmed, a start-up in the field of evidence-based cognitive training (clinically validated software), based in Stockholm and later in the US. Jonas took the company from the research phase at the Karolinska Institute in 2001, to acquisition by Pearson, in 2010. Before joining Industrifonden in 2017, Jonas also held various advisor and board member roles, in both early stage and public companies, and across digital health (such as Shim, acquired by Kry), medtech and biotech (such as Bioinvent). His background also includes strategy work with The Boston Consulting Group. Jonas holds a M.Sc. from the Stockholm School of Economics.
Other Seats	Elypta	Elypta